<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19163" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cerebellar Hematoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fischer</surname>
            <given-names>Michelle A.</given-names>
          </name>
          <aff>Penn State Hershey Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Das</surname>
            <given-names>Joe M.</given-names>
          </name>
          <aff>Imperial College Healthcare NHS Trust, London</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michelle Fischer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joe Das declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19163.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cerebellar hemorrhage or hematoma is a type of intracranial hemorrhage in which the bleeding is located in the posterior fossa or cerebellum. This condition is most frequently seen in middle-aged and older adults. Cerebellar hematomas can block the normal flow of cerebral spinal fluid leading to hydrocephalus, increased intracranial pressure, and the onset of symptoms. Cerebellar hemorrhage can be spontaneous or secondary to stroke or trauma. Cerebellar hemorrhages are associated with high morbidity and mortality. This activity reviews the evaluation and management of a cerebellar hematoma and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify clinical examination findings suggestive of a cerebellar hematoma.</p></list-item><list-item><p>Describe diagnostic and imaging strategies for patients presenting with features concerning for cerebellar hematoma.</p></list-item><list-item><p>Outline the treatment and management options for cerebellar hemorrhage.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance the treatment of cerebellar hemorrhage and improve patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19163&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19163">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19163.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cerebellar hemorrhage or hematoma is a type of intracranial hemorrhage (ICH) where the bleeding is located in the posterior fossa or cerebellum and accounts for 9% to 10% of all ICH.<xref ref-type="bibr" rid="article-19163.r1">[1]</xref> The posterior fossa is a small space in the skull&#x000a0;containing the brainstem and cerebellum. If a mass such as a hemorrhage&#x000a0;grows&#x000a0;in this region, particularly the brainstem and 4th ventricle, it can block the normal flow of cerebral spinal fluid leading to hydrocephalus, increased intracranial pressure, and symptoms onset. Cerebellar hemorrhage can be spontaneous, a result of a stroke or secondary to trauma, and occurs most frequently in middle-aged and older adults. Patients typically have underlying risk factors leading to hemorrhages such as hypertension or small vessel disease. The clinical presentation is dependent upon the&#x000a0;size and location of the hematoma as well as the location and amount of edema of associated structures in the posterior fossa. The initial imaging modality is typically a non-contrast computed tomography (CT) scan. Management spans the spectrum from close observation to acute surgical intervention with optimal timing of surgery.</p>
      </sec>
      <sec id="article-19163.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The most common non-traumatic etiology for cerebellar hemorrhage as for all intracranial hemorrhages is hypertensive vasculopathy causing microaneurysms and resultant rupture. Cerebellar hemorrhage from hypertension most commonly occurs in the middle-aged or older population, often in the dentate nucleus with extension to other areas from the rupture of microaneurysms along the penetrating small vessels. Other causes of cerebellar hemorrhage include trauma, coagulopathy (cirrhosis, disseminated intravascular coagulation or thrombocytopenia) or bleeding disorders (primary and drug-induced (anticoagulation, antiplatelet or thrombolytic medications)), ischemic stroke with hemorrhagic transformation, cerebral amyloid angiopathy,<xref ref-type="bibr" rid="article-19163.r2">[2]</xref> vascular malformations such as arteriovenous malformation (AVM), dural arteriovenous fistula in the tentorium,<xref ref-type="bibr" rid="article-19163.r3">[3]</xref> brain tumors (primary or metastatic),<xref ref-type="bibr" rid="article-19163.r4">[4]</xref><xref ref-type="bibr" rid="article-19163.r5">[5]</xref> septic embolism, central nervous system infection (encephalitis, moyamoya disease, vasculitis (lupus)), sympathomimetic drugs such as cocaine and amphetamines,<xref ref-type="bibr" rid="article-19163.r6">[6]</xref> aneurysm (posterior circulation) or remote hemorrhage following supratentorial neurosurgical procedure.<xref ref-type="bibr" rid="article-19163.r7">[7]</xref></p>
        <p>The most common primary central nervous system (CNS) tumors to undergo hemorrhagic transformation are glioblastomas. The metastatic CNS tumors that are more prone to hemorrhage include lesions from the lung, breast, kidney, and melanomas. Cerebellar hemorrhage in younger patients may be due to substance abuse, trauma, or CNS aneurysms, or AVMs.</p>
      </sec>
      <sec id="article-19163.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Nontraumatic intracranial hemorrhage varies by race and age, but overall it is the cause of 9% to 27% of strokes globally with an annual incidence of 12 to 31 per 100000 people.<xref ref-type="bibr" rid="article-19163.r8">[8]</xref><xref ref-type="bibr" rid="article-19163.r9">[9]</xref>&#x000a0;Cerebellar hemorrhage occurs in approximately 10% of all ICH with a low annual incidence of 1% to 2% in all strokes. The incidence of ICH increases with age, doubling every 10 years after age 35.<xref ref-type="bibr" rid="article-19163.r10">[10]</xref><xref ref-type="bibr" rid="article-19163.r11">[11]</xref> The rate is highest in the Asian populations, lowest in Whites, with Blacks having an intermediate occurrence rate.<xref ref-type="bibr" rid="article-19163.r12">[12]</xref></p>
      </sec>
      <sec id="article-19163.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The cerebellar location is not unique as far as the causes of intracranial hemorrhage. The prevailing belief is that patients with long-standing hypertension have degenerative changes in the penetrating small blood vessel walls leading to the subsequent formation of microaneurysms that rupture and hemorrhage.<xref ref-type="bibr" rid="article-19163.r13">[13]</xref>&#x000a0;Tumors, blood disorders, amyloid, arteriovenous malformation, trauma, and stimulant drug abuse may also lead to cerebellar hemorrhage. Remote cerebellar hemorrhage after craniotomies is thought to be a result of a loss of cerebral spinal fluid (CSF), causing a "sag" in the cerebellum with resultant venous bleeding often tracking along the superior cerebellum with most cases having a benign course.<xref ref-type="bibr" rid="article-19163.r14">[14]</xref></p>
      </sec>
      <sec id="article-19163.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Symptom onset is typically abrupt, with a significant variation of symptom presentation dependent on the location and size of the hemorrhage. Some patients with smaller cerebellar hemorrhage remain awake and may complain of headache, nausea, vomiting, vertigo, or ataxia. If the hemorrhage is large, patients may present with an altered level of consciousness or even unresponsiveness. Symptoms may change suddenly, correlating with hematoma expansion. Symptoms may also occur during stressful situations or strenuous activity. A detailed history is critical, noting any of the following: a history of hypertension, coagulopathy including chemically induced, head trauma, known history of an intracranial aneurysm, or arteriovenous&#x000a0;malformation (AVM),&#x000a0;history of malignancy, and use of sympathomimetic drugs (cocaine and amphetamines). Symptom presentation in descending order of frequency include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Abrupt onset headache</p>
          </list-item>
          <list-item>
            <p>Nausea and vomiting</p>
          </list-item>
          <list-item>
            <p>Difficulty with ambulation (truncal ataxia)</p>
          </list-item>
          <list-item>
            <p>Vertigo and dizziness</p>
          </list-item>
          <list-item>
            <p>Dysarthria</p>
          </list-item>
          <list-item>
            <p>Neck pain or nuchal rigidity</p>
          </list-item>
          <list-item>
            <p>Loss of consciousness or altered mental status</p>
          </list-item>
        </list>
        <p>Physical examination is also variable and dependent on hemorrhage location, with some patients awake and others unresponsive. Cerebellar signs may include any combination of the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Limb ataxia</p>
          </list-item>
          <list-item>
            <p>Dysarthria</p>
          </list-item>
          <list-item>
            <p>Nystagmus</p>
          </list-item>
          <list-item>
            <p>Abnormal gaze or facial weakness (cranial nerve palsy ipsilateral to the hematoma)</p>
          </list-item>
          <list-item>
            <p>Abnormal gait</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19163.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Noncontrast head computerized tomography (CT) imaging is quick and widely available so it is typically the first and most efficient method of evaluation for those patients&#x000a0;who present with signs and symptoms&#x000a0;of possible cerebellar hemorrhage. Most hemorrhages are readily identified&#x000a0;as hyperdense lesions in the cerebellum. On occasion, dense calcification of the dentate nucleus can be confused with hemorrhage, but the absence of a mass effect, sharp margins, and bilateral presence should point more towards calcification over a hemorrhage. Contrast extravasation following an endovascular procedure will also appear dense like a cerebellar hemorrhage, but dual-energy CT can differentiate the two.<xref ref-type="bibr" rid="article-19163.r15">[15]</xref>&#x000a0;Further imaging modalities that may help in the further delineation of the lesion may be CT angiogram, magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), or angiography.</p>
      </sec>
      <sec id="article-19163.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of cerebellar hemorrhage is dependent on the size of the hemorrhage in addition&#x000a0;to the clinical presentation. Airway protection with endotracheal intubation may be necessary for patients who present with severely altered and depressed level of consciousness or altered mental status (GCS less than 8). Neurosurgical consultation should be obtained urgently after diagnosis to assist with optimal management and treatment. Small hemorrhages without significant mass effect can often be managed conservatively with admission to a critical care unit capable of frequent neurologic assessments. Large hemorrhages, typically greater than 3 to 4 cm, may require surgical intervention and evacuation, particularly&#x000a0;if associated with edema, intraventricular extension, brainstem displacement, or hydrocephalus. If patients are intubated, normocarbia should be maintained. There is no need for prophylactic hyperventilation except in the extreme cases of impending brainstem herniation, and it should only be for a short period.<xref ref-type="bibr" rid="article-19163.r16">[16]</xref>&#x000a0;Corticosteroids have not demonstrated any benefit in the treatment of cerebellar hemorrhage.&#x000a0;</p>
        <p>Patients with cerebellar hemorrhage often have an acute blood pressure elevation, as in any other case of intracranial hemorrhage. It is often a fine balance to aim to minimize hemorrhage growth and increased intracranial pressure while maintaining cerebral perfusion. A recent consensus&#x000a0;recommendation believes it is safe to lower the blood pressure to less than 140 mm Hg systolic.<xref ref-type="bibr" rid="article-19163.r17">[17]</xref><xref ref-type="bibr" rid="article-19163.r18">[18]</xref> The 2010 American Heart Association guidelines on the management&#x000a0;of blood pressure in intracerebral hemorrhage&#x000a0;suggest values less than 160/90 mm Hg or a mean arterial pressure (MAP) less than 110 mm Hg.<xref ref-type="bibr" rid="article-19163.r19">[19]</xref> Body temperature should be maintained within the normal range, and if the patient does develop an elevated body temperature, pharmacotherapy or cooling measures should be instituted to maintain a core body temperature of lower than 37.5 C as the fever has been shown to worsen outcomes in the injured brain.<xref ref-type="bibr" rid="article-19163.r20">[20]</xref>&#x000a0;Current evidence does not support hypothermia for cerebellar hemorrhage. Maintaining normal glucose levels is necessary as hyperglycemia has correlations with poorer outcomes in patients with cerebellar hemorrhage.<xref ref-type="bibr" rid="article-19163.r21">[21]</xref><xref ref-type="bibr" rid="article-19163.r22">[22]</xref>&#x000a0;Hypoglycemia should also be avoided, and current practice suggests a reasonable glucose range of 100 to 180 mg/dL.<xref ref-type="bibr" rid="article-19163.r23">[23]</xref> In the intensive care setting, insulin therapy over oral agents is preferred. Intensive compared to conventional glucose control did not demonstrate any significant difference in clinical outcomes.<xref ref-type="bibr" rid="article-19163.r24">[24]</xref><xref ref-type="bibr" rid="article-19163.r25">[25]</xref> Normovolemia should be maintained with isotonic fluids with appropriate correction of serum electrolytes such as sodium, potassium, and magnesium. Mild hypertonic fluid such as 1.5% hypertonic saline may be used to correct hyponatremia. Cardiac arrhythmias may occur with an injured brain, and it is important to keep the potassium level above 4.0 mmol/L and magnesium above 2.0 mg/dL so as not to aggravate arrhythmias.&#x000a0;</p>
        <p>Anticoagulation and/or antiplatelet medications should be immediately discontinued in cases of cerebellar hemorrhage. The reversal of the coagulopathy should take place with an appropriate reversal agent. Patients on warfarin should receive vitamin K (10 mg) and factor replacement in the form of fresh frozen plasma (FFP) or prothrombin complex concentrate (PCC), both of which are effective.<xref ref-type="bibr" rid="article-19163.r26">[26]</xref> Factor replacement with PCC or 4-factor-PCC should be attempted in patients on novel oral anticoagulants, but supporting evidence is limited.<xref ref-type="bibr" rid="article-19163.r27">[27]</xref><xref ref-type="bibr" rid="article-19163.r28">[28]</xref>&#x000a0;Platelet replacement therapy in patients on antiplatelet medications or those with thrombocytopenia and platelet counts less than 50000&#x000a0;is often performed with severe bleeding and before surgical intervention, but the benefit is unknown.</p>
      </sec>
      <sec id="article-19163.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for patients presenting with any combination of sudden onset of symptoms such as headache, nausea, vomiting, dizziness, or vertigo includes both central and peripheral disease processes.</p>
        <p>Central&#x000a0;causes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute demyelinating disorder such as multiple sclerosis (MS) or encephalitis</p>
          </list-item>
          <list-item>
            <p>Alcohol use disorder</p>
          </list-item>
          <list-item>
            <p>Cerebellar hemorrhage</p>
          </list-item>
          <list-item>
            <p>Cerebellar infarction</p>
          </list-item>
          <list-item>
            <p>Cerebellar neoplasm</p>
          </list-item>
          <list-item>
            <p>Cerebellitis</p>
          </list-item>
          <list-item>
            <p>Illicit drug use</p>
          </list-item>
          <list-item>
            <p>Medication toxicity (phenytoin or carbamazepine)</p>
          </list-item>
        </list>
        <p>Peripheral causes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Benign paroxysmal positional vertigo (BPPV)</p>
          </list-item>
          <list-item>
            <p>Labyrinthitis</p>
          </list-item>
          <list-item>
            <p>Meniere disease</p>
          </list-item>
          <list-item>
            <p>Vestibular&#x000a0;neuronitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19163.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The mortality associated with cerebellar hemorrhage can range from 25% to 57%.<xref ref-type="bibr" rid="article-19163.r29">[29]</xref><xref ref-type="bibr" rid="article-19163.r30">[30]</xref>&#x000a0;Outcomes following&#x000a0;surgery are strongly&#x000a0;correlated with&#x000a0;the patient's clinical status before surgery but are favorable in over half of the cases.<xref ref-type="bibr" rid="article-19163.r29">[29]</xref><xref ref-type="bibr" rid="article-19163.r31">[31]</xref>&#x000a0;Recommendations are, therefore,&#x000a0;that in the absence of multiple comorbidities, surgical intervention should be pursued even in patients with poor preoperative neurologic status.</p>
      </sec>
      <sec id="article-19163.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Significant cerebellar hemorrhage may have&#x000a0;peri-hemorrhagic edema and mass effect, which, unfortunately, can cause multiple complications, including brainstem compression, cerebellar herniation, compression of the fourth ventricle with resultant obstructive hydrocephalus, an extension of hemorrhage into the ventricular system, and recurrent hemorrhage typically within the first 24 hours. There are two options for managing the mass effect from the cerebellar hemorrhage: (1) hyperosmolar agents or (2) decompressive surgery.</p>
        <p>Osmolar therapy is used to reduce the space-occupying effects of hemorrhage and edema by increasing serum osmolality and facilitating an osmotic movement of water into the vasculature with resultant reactive vasoconstriction. The goal is an overall reduction in intracranial pressure and tissue shrinkage. There is no superiority of hypertonic saline over mannitol or vice versa for the treatment of intracranial hemorrhage. Hypertonic saline concentrations typically utilized for treatment are 3% (250 mL bolus), 10% (75 to 150 mL bolus), and 23.4% (30 mL bolus). Boluses and continuous infusions have the goal of sodium levels of 145 to 155 mmol/L and osmolality of 310 to 320 mOsm/kg.<xref ref-type="bibr" rid="article-19163.r32">[32]</xref>&#x000a0;Complications may occur with infusions such as hypotension, pulmonary edema, heart failure, coagulopathy, hypokalemia, intravascular hemolysis, and encephalopathy, but these are rare.<xref ref-type="bibr" rid="article-19163.r33">[33]</xref>&#x000a0;Mannitol is a sugar alcohol that acts as a diuretic and is usually administered as a 1 to 2 g/kg bolus (20% concentration) with additional doses of 0.5 g/kg every 4 to 6 hours.<xref ref-type="bibr" rid="article-19163.r34">[34]</xref><xref ref-type="bibr" rid="article-19163.r35">[35]</xref>&#x000a0;It is imperative to maintain euvolemia during its administration, and caution is advised in patients with renal failure as the mannitol may lead to fluid overload, necessitating dialysis shortly after administration. Serum osmolality should remain at less than 320 mOsm/kg to prevent renal toxicity.</p>
        <p>Decompressive surgery of choice is a suboccipital craniectomy with hematoma evacuation.<xref ref-type="bibr" rid="article-19163.r36">[36]</xref><xref ref-type="bibr" rid="article-19163.r37">[37]</xref>&#x000a0;The surgical option is necessary when the patient's neurologic status continues to decline due to brainstem compression or obstructive hydrocephalus, and it appears secondary to the mass effect of the hemorrhage and peri-hemorrhagic edema. An external ventricular drain (EVD) may be used to treat the obstructive hydrocephalus as an alternative to surgery or in addition&#x000a0;to surgery. Criteria used to select patients for surgery and/or EVD placement have their basis on both clinical presentation and radiographic features such as the size of the hematoma, ventricular extension, hydrocephalus, brainstem compression, and cisternal effacement.<xref ref-type="bibr" rid="article-19163.r38">[38]</xref><xref ref-type="bibr" rid="article-19163.r39">[39]</xref>&#x000a0;Hemorrhages less than 3 cm in diameter without evidence of brainstem compression or hydrocephalus may be treated with close observation in an intensive care setting without surgery. A stereotactic burr-hole aspiration is an option for patients with smaller hemorrhages.<xref ref-type="bibr" rid="article-19163.r40">[40]</xref></p>
      </sec>
      <sec id="article-19163.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Most cerebellar hemorrhages are hypertensive in origin. Patients suffering from hypertension should receive an education so that they are aware of all the potential risks and complications associated with poor control of their disease process. These patients should be encouraged to seek medical attention urgently if they develop worrisome symptoms.</p>
      </sec>
      <sec id="article-19163.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of a cerebellar hemorrhage are with an interprofessional team that includes a combination of the following: emergency clinician, neurosurgeon, neurologist, primary care provider, intensivist, and&#x000a0;acute practice&#x000a0;provider. The nurses who usually monitor these patients have specialty training in neuroscience and know what signs and symptoms to watch for the progression of the disorder. They must discuss abnormal findings with the clinicians as quickly as possible. The interprofessional team also includes providers and pharmacists, which is considered the best approach to the management of these cases for optimal care and outcomes. The presentation of cerebellar hemorrhage may be subtle to a patient in extremis and is often not easy, requiring intensive management and treatment. The majority of patients are managed in a critical care setting with frequent neurologic assessments, blood pressure control, electrolyte, and intravenous fluid management, and supportive care. Management requires treatment with multiple pharmacologic agents. The pharmacist should manage medication reconciliation and consider potential drug interactions reporting to the team concerning drug interactions. [Level 5]</p>
        <p>The outcome depends on the severity of the bleeding, the presence of neurological deficit, the age of the patient, and other associated co-morbidity. An interprofessional team approach to the evaluation and education of the&#x000a0;patient and family will lead to the best outcomes.</p>
      </sec>
      <sec id="article-19163.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19163&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19163">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/cerebellar-hematoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19163">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19163/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19163">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-19163.s15">
        <fig id="article-19163.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Cerebellar hemorrhage Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cerebellar__hemorrhage" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19163.s16">
        <fig id="article-19163.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Cerebellar hematoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CEREBELLAR__HEMATOMA" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-19163.s17">
        <fig id="article-19163.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Cerebellar hematoma Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CEREBELLAR__HEMATOMA" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-19163.s18">
        <title>References</title>
        <ref id="article-19163.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Datar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rabinstein</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Cerebellar hemorrhage.</article-title>
            <source>Neurol Clin</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>993</fpage>
            <page-range>993-1007</page-range>
            <pub-id pub-id-type="pmid">25439293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Itoh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hayakawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Otomo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Miyatake</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly.</article-title>
            <source>J Neurol Sci</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>116</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-41</page-range>
            <pub-id pub-id-type="pmid">8336159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satoh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Satomi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nagahiro</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cerebellar hemorrhage caused by dural arteriovenous fistula: a review of five cases.</article-title>
            <source>J Neurosurg</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>422</fpage>
            <page-range>422-6</page-range>
            <pub-id pub-id-type="pmid">11235946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>OL</given-names>
              </name>
            </person-group>
            <article-title>Cerebellar pilocytic astrocytomas with spontaneous intratumoral hemorrhage in adult.</article-title>
            <source>J Korean Neurosurg Soc</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>363</fpage>
            <page-range>363-6</page-range>
            <pub-id pub-id-type="pmid">21887396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mesiwala</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Avellino</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Ellenbogen</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous cerebellar hemorrhage due to a juvenile pilocytic astrocytoma: case report and review of the literature.</article-title>
            <source>Pediatr Neurosurg</source>
            <year>2001</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>235</fpage>
            <page-range>235-8</page-range>
            <pub-id pub-id-type="pmid">11423772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cordonnier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Demchuk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ziai</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Intracerebral haemorrhage: current approaches to acute management.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Oct</month>
            <day>06</day>
            <volume>392</volume>
            <issue>10154</issue>
            <fpage>1257</fpage>
            <page-range>1257-1268</page-range>
            <pub-id pub-id-type="pmid">30319113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Piepgras</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Remote cerebellar hemorrhage.</article-title>
            <source>J Neurosurg</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>2</issue>
            <fpage>498</fpage>
            <page-range>498-9; author reply 499</page-range>
            <pub-id pub-id-type="pmid">12186489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feigin</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Lawes</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Barker-Collo</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Parag</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.</article-title>
            <source>Lancet Neurol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-69</page-range>
            <pub-id pub-id-type="pmid">19233729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steiner</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Al-Shahi Salman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ntaios</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The European Stroke Organisation (ESO) guidelines.</article-title>
            <source>Int J Stroke</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>7</issue>
            <fpage>838</fpage>
            <page-range>838-9</page-range>
            <pub-id pub-id-type="pmid">25231578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broderick</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Brott</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tomsick</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Huster</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage.</article-title>
            <source>J Neurosurg</source>
            <year>1993</year>
            <month>Feb</month>
            <volume>78</volume>
            <issue>2</issue>
            <fpage>188</fpage>
            <page-range>188-91</page-range>
            <pub-id pub-id-type="pmid">8421201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Misselwitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hamann</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Scharbrodt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Schummer</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Oertel</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Intracerebral hemorrhage in the very old: future demographic trends of an aging population.</article-title>
            <source>Stroke</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>1126</fpage>
            <page-range>1126-8</page-range>
            <pub-id pub-id-type="pmid">22282880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flaherty</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Haverbusch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sekar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khoury</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sauerbeck</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moomaw</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kissela</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kleindorfer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Racial variations in location and risk of intracerebral hemorrhage.</article-title>
            <source>Stroke</source>
            <year>2005</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>934</fpage>
            <page-range>934-7</page-range>
            <pub-id pub-id-type="pmid">15790947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Pathology of hypertensive arteriopathy.</article-title>
            <source>Neurosurg Clin N Am</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>497</fpage>
            <page-range>497-507</page-range>
            <pub-id pub-id-type="pmid">1633473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Piepgras</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Duke</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>McClelland</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Bechtle</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Maher</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Morita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perkins</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Parisi</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Remote cerebellar hemorrhage after supratentorial surgery.</article-title>
            <source>Neurosurgery</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>1327</fpage>
            <page-range>1327-40</page-range>
            <pub-id pub-id-type="pmid">11846932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Phan</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Leidecker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brady</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of dual-energy CT for differentiating intracerebral hemorrhage from iodinated contrast material staining.</article-title>
            <source>Radiology</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>257</volume>
            <issue>1</issue>
            <fpage>205</fpage>
            <page-range>205-11</page-range>
            <pub-id pub-id-type="pmid">20679449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wijdicks</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Sheth</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kasner</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kimberly</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Schwab</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Tamargo</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wintermark</surname>
                <given-names>M</given-names>
              </name>
              <collab>American Heart Association Stroke Council</collab>
            </person-group>
            <article-title>Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association.</article-title>
            <source>Stroke</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>1222</fpage>
            <page-range>1222-38</page-range>
            <pub-id pub-id-type="pmid">24481970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Heeley</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stapf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Delcourt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lindley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lavados</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Neal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heritier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simes</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Chalmers</surname>
                <given-names>J</given-names>
              </name>
              <collab>INTERACT2 Investigators</collab>
            </person-group>
            <article-title>Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Jun</month>
            <day>20</day>
            <volume>368</volume>
            <issue>25</issue>
            <fpage>2355</fpage>
            <page-range>2355-65</page-range>
            <pub-id pub-id-type="pmid">23713578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Heeley</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Neal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Skulina</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>QL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Tai</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Chalmers</surname>
                <given-names>J</given-names>
              </name>
              <collab>Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial Investigators</collab>
            </person-group>
            <article-title>Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage.</article-title>
            <source>Hypertension</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>56</volume>
            <issue>5</issue>
            <fpage>852</fpage>
            <page-range>852-8</page-range>
            <pub-id pub-id-type="pmid">20823381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgenstern</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Hemphill</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>MacDonald</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Mess&#x000e9;</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Selim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tamargo</surname>
                <given-names>RJ</given-names>
              </name>
              <collab>American Heart Association Stroke Council and Council on Cardiovascular Nursing</collab>
            </person-group>
            <article-title>Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.</article-title>
            <source>Stroke</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>9</issue>
            <fpage>2108</fpage>
            <page-range>2108-29</page-range>
            <pub-id pub-id-type="pmid">20651276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwarz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>H&#x000e4;fner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aschoff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schwab</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Incidence and prognostic significance of fever following intracerebral hemorrhage.</article-title>
            <source>Neurology</source>
            <year>2000</year>
            <month>Jan</month>
            <day>25</day>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>354</fpage>
            <page-range>354-61</page-range>
            <pub-id pub-id-type="pmid">10668696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemia as a predictor of poor outcome at discharge in patients with acute spontaneous cerebellar hemorrhage.</article-title>
            <source>Cerebellum</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>543</fpage>
            <page-range>543-8</page-range>
            <pub-id pub-id-type="pmid">21975857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kimura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Iguchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shibazaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage.</article-title>
            <source>J Neurol Sci</source>
            <year>2007</year>
            <month>Apr</month>
            <day>15</day>
            <volume>255</volume>
            <issue>1-2</issue>
            <fpage>90</fpage>
            <page-range>90-4</page-range>
            <pub-id pub-id-type="pmid">17350046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Godoy</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Di Napoli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rabinstein</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Treating hyperglycemia in neurocritical patients: benefits and perils.</article-title>
            <source>Neurocrit Care</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>425</fpage>
            <page-range>425-38</page-range>
            <pub-id pub-id-type="pmid">20652767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>NICE-SUGAR Study Investigators</collab>
              <name>
                <surname>Finfer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chittock</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dhingra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bellomo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dodek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>H&#x000e9;bert</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Heritier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heyland</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>McArthur</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Myburgh</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Ronco</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Intensive versus conventional glucose control in critically ill patients.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Mar</month>
            <day>26</day>
            <volume>360</volume>
            <issue>13</issue>
            <fpage>1283</fpage>
            <page-range>1283-97</page-range>
            <pub-id pub-id-type="pmid">19318384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group</collab>
              <name>
                <surname>Finfer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chittock</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dhingra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bellomo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dodek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hebert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Heyland</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McArthur</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Myburgh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ronco</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study.</article-title>
            <source>Intensive Care Med</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>1037</fpage>
            <page-range>1037-47</page-range>
            <pub-id pub-id-type="pmid">26088909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sj&#x000f6;blom</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>H&#x000e5;rdemark</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Lindgren</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Norrving</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fahl&#x000e9;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Samuelsson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stigendal</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stockelberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Taghavi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wallrup</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wallvik</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study.</article-title>
            <source>Stroke</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>11</issue>
            <fpage>2567</fpage>
            <page-range>2567-74</page-range>
            <pub-id pub-id-type="pmid">11692018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siegal</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Crowther</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>How I treat target-specific oral anticoagulant-associated bleeding.</article-title>
            <source>Blood</source>
            <year>2014</year>
            <month>Feb</month>
            <day>20</day>
            <volume>123</volume>
            <issue>8</issue>
            <fpage>1152</fpage>
            <page-range>1152-8</page-range>
            <pub-id pub-id-type="pmid">24385535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pernod</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Albaladejo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Godier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Samama</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Susen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gruel</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Blais</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fontana</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Llau</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Rosencher</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Schved</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>de Maistre</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Samama</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Mismetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Si&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <collab>Working Group on Perioperative Haemostasis</collab>
            </person-group>
            <article-title>Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.</article-title>
            <source>Arch Cardiovasc Dis</source>
            <year>2013</year>
            <season>Jun-Jul</season>
            <volume>106</volume>
            <issue>6-7</issue>
            <fpage>382</fpage>
            <page-range>382-93</page-range>
            <pub-id pub-id-type="pmid">23810130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dammann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Asgari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bassiouni</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gasser</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Panagiotopoulos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gizewski</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Stolke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sure</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Sandalcioglu</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous cerebellar hemorrhage--experience with 57 surgically treated patients and review of the literature.</article-title>
            <source>Neurosurg Rev</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-86</page-range>
            <pub-id pub-id-type="pmid">20697766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yanaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meguro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Narushima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nose</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Postoperative brainstem high intensity is correlated with poor outcomes for patients with spontaneous cerebellar hemorrhage.</article-title>
            <source>Neurosurgery</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>1323</fpage>
            <page-range>1323-7; discussion 1327-8</page-range>
            <pub-id pub-id-type="pmid">10598699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ott</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kase</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Ojemann</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Mohr</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases.</article-title>
            <source>Arch Neurol</source>
            <year>1974</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-7</page-range>
            <pub-id pub-id-type="pmid">4546748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hauer</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Staykov</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Steigleder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schwab</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bardutzky</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease.</article-title>
            <source>Crit Care Med</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>1766</fpage>
            <page-range>1766-72</page-range>
            <pub-id pub-id-type="pmid">21494103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ziai</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Toung</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Bhardwaj</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hypertonic saline: first-line therapy for cerebral edema?</article-title>
            <source>J Neurol Sci</source>
            <year>2007</year>
            <month>Oct</month>
            <day>15</day>
            <volume>261</volume>
            <issue>1-2</issue>
            <fpage>157</fpage>
            <page-range>157-66</page-range>
            <pub-id pub-id-type="pmid">17585941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Videen</surname>
                <given-names>TO</given-names>
              </name>
              <name>
                <surname>Zazulia</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Manno</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Derdeyn</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Diringer</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke.</article-title>
            <source>Neurology</source>
            <year>2001</year>
            <month>Dec</month>
            <day>11</day>
            <volume>57</volume>
            <issue>11</issue>
            <fpage>2120</fpage>
            <page-range>2120-2</page-range>
            <pub-id pub-id-type="pmid">11739839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diringer</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Scalfani</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Zazulia</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Videen</surname>
                <given-names>TO</given-names>
              </name>
              <name>
                <surname>Dhar</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke.</article-title>
            <source>Neurocrit Care</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-7</page-range>
            <pub-id pub-id-type="pmid">21042881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yanaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meguro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Narushima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nose</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Immediate surgery reduces mortality in deeply comatose patients with spontaneous cerebellar hemorrhage.</article-title>
            <source>Neurol Med Chir (Tokyo)</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>295</fpage>
            <page-range>295-9; discussion 299-300</page-range>
            <pub-id pub-id-type="pmid">10892265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kageyama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yamaura</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment of hypertensive cerebellar hemorrhage--surgical or conservative management?</article-title>
            <source>Neurosurgery</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>246</fpage>
            <page-range>246-50; discussion 250-1</page-range>
            <pub-id pub-id-type="pmid">8177384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taneda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hayakawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mogami</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Primary cerebellar hemorrhage. Quadrigeminal cistern obliteration on CT scans as a predictor of outcome.</article-title>
            <source>J Neurosurg</source>
            <year>1987</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>545</fpage>
            <page-range>545-52</page-range>
            <pub-id pub-id-type="pmid">3655893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luparello</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Canavero</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment of hypertensive cerebellar hemorrhage--surgical or conservative management?</article-title>
            <source>Neurosurgery</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>552</fpage>
            <page-range>552-3</page-range>
            <pub-id pub-id-type="pmid">7501127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19163.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Stereotactic burr hole aspiration surgery for spontaneous hypertensive cerebellar hemorrhage.</article-title>
            <source>J Cerebrovasc Endovasc Neurosurg</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>170</fpage>
            <page-range>170-4</page-range>
            <pub-id pub-id-type="pmid">23210043</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
